MR characterisation of dysplastic nodules and hepatocarcinoma in the cirrhotic liver with hepatospecific superparamagnetic contrast agents: pathological correlation in explanted livers
- PMID: 19902328
- DOI: 10.1007/s11547-009-0464-9
MR characterisation of dysplastic nodules and hepatocarcinoma in the cirrhotic liver with hepatospecific superparamagnetic contrast agents: pathological correlation in explanted livers
Abstract
Purpose: The authors sought to evaluate the potential of magnetic resonance (MR) imaging with superparamagnetic iron oxide (SPIO) contrast material for identifying, characterising and differentiating dysplastic nodules (DN) and hepatocellular carcinoma (HCC) in the cirrhotic liver by correlating the results with pathological findings on the explanted liver.
Material and methods: MR imaging was used to study the liver of 400 cirrhotic patients awaiting liver transplantation, 31 of whom were selected to receive a liver. Of these 31 patients, we included in the study 22 patients (mean age 53 years; range 46-57 years) who underwent liver transplantation within 12-24 h after MR examination. Patients were studied with a 1.5-T device, and scans were acquired before and after the administration of paramagnetic contrast material. For every lesion, we recorded signal intensity on unenhanced baseline T1- and T2-weighted images and enhancement pattern after SPIO administration. Histological examination of the entire liver provided the definitive diagnosis of the lesions.
Results: Histological examination identified 59 lesions: 14 HCC, 4 HCC-DN, 39 DN, and 2 cystoadenomas. Among the 14 HCC, three were well differentiated, eight were moderately differentiated and three were poorly differentiated. Of the 39 DN, 28 were low-grade and 11 high-grade lesions. Unenhanced baseline MR imaging correctly identified and characterised 20 lesions, equal to 33.90% of all lesions: 6 HCC, 12 DN and 2 DN with a subfocus of HCC. SPIO-enhanced MR imaging showed greater sensitivity detecting and characterising 45 lesions, equal to 76.27% of all lesions identified at histology: 14 HCC, 27 DN and 4 DN with subfocus of HCC. SPIO administration improved the sensitivity of MR imaging in lesion detection and characterisation by 42.37%. False negative results with SPIO-enhanced MR imaging occurred in 12 DN (31%), which histological examination revealed to be low-grade DN with a diameter <1 cm.
Conclusions: SPIO-enhanced MR imaging proved to be of value in detecting and characterising lesions in the cirrhotic liver, allowing differentiation of DN from HCC and providing an early diagnosis of neoplastic degeneration of DN.
Similar articles
-
Double-contrast MRI (DC-MRI) in the study of the cirrhotic liver: utility of administering Gd-DTPA as a complement to examinations in which SPIO liver uptake and distribution alterations (SPIO-LUDA) are present and in the identification and characterisation of focal lesions.Radiol Med. 2006 Dec;111(8):1087-102. doi: 10.1007/s11547-006-0107-3. Epub 2006 Dec 20. Radiol Med. 2006. PMID: 17171525 English, Italian.
-
Differentiation of well-differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: value of SPIO-enhanced MR imaging at 3.0 Tesla.J Magn Reson Imaging. 2009 Feb;29(2):328-35. doi: 10.1002/jmri.21615. J Magn Reson Imaging. 2009. PMID: 19161184
-
Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.AJR Am J Roentgenol. 1999 Jun;172(6):1547-54. doi: 10.2214/ajr.172.6.10350287. AJR Am J Roentgenol. 1999. PMID: 10350287
-
Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma.Eur J Radiol. 2006 May;58(2):200-16. doi: 10.1016/j.ejrad.2005.11.040. Epub 2006 Jan 18. Eur J Radiol. 2006. PMID: 16414230 Review.
-
Problematic lesions in cirrhotic liver mimicking hepatocellular carcinoma.Eur Radiol. 2019 Sep;29(9):5101-5110. doi: 10.1007/s00330-019-06030-0. Epub 2019 Feb 20. Eur Radiol. 2019. PMID: 30788586 Review.
Cited by
-
MRI features of hepatocellular carcinoma related to biologic behavior.Korean J Radiol. 2015 May-Jun;16(3):449-64. doi: 10.3348/kjr.2015.16.3.449. Epub 2015 May 13. Korean J Radiol. 2015. PMID: 25995679 Free PMC article. Review.
-
Advances in magnetic particle imaging and perspectives on liver imaging.ILIVER. 2022 Nov 8;1(4):237-244. doi: 10.1016/j.iliver.2022.10.003. eCollection 2022 Dec. ILIVER. 2022. PMID: 40636343 Free PMC article. Review.
-
Superparamagnetic iron oxide-enhanced magnetic resonance imaging for focal hepatic lesions: systematic review and meta-analysis.World J Gastroenterol. 2015 Apr 14;21(14):4334-44. doi: 10.3748/wjg.v21.i14.4334. World J Gastroenterol. 2015. PMID: 25892885 Free PMC article.
-
Diagnostic and therapeutic roles of iron oxide nanoparticles in biomedicine.Tzu Chi Med J. 2022 Jul 27;35(1):11-17. doi: 10.4103/tcmj.tcmj_65_22. eCollection 2023 Jan-Mar. Tzu Chi Med J. 2022. PMID: 36866343 Free PMC article. Review.
-
Magnetic Relaxation Switching Assay Using IFNα-2b-Conjugated Superparamagnetic Nanoparticles for Anti-Interferon Antibody Detection.Biosensors (Basel). 2023 Jun 5;13(6):624. doi: 10.3390/bios13060624. Biosensors (Basel). 2023. PMID: 37366989 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical